Form 4 for GLSI Greenwich LifeSciences, Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001493152-24-047527 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-21 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $12.91 | +1,000 | 264.1K | +0.4% | +$12.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-21 | P | A | 1,000 | $12.91 | 264,148 | D | — | — |